Skip to main content
SpringerLink
Log in

Cognitive impairment in multiple sclerosis

  • Published:
Journal of Neurology Aims and scope Submit manuscript

An Erratum to this article was published on 01 February 2008

Abstract

Cognitive dysfunctions are frequent symptoms of multiple sclerosis (MS) and occur in up to 65% of patients. Especially memory, attention, executive and visual constructive functions are impaired. These problems strongly affect patients' ability to work, social relationships, and quality of life. Symptoms of physical disabilities can arise independently. Cognitive dysfunctions are clear indicators of MS progression, because they represent highly complex functions that depend on the integrity of the neuronal networks. Once manifested after a relapse, they remain stable . Given a differentiating diagnosis, it is possible to treat these dysfunctions by cognitive training and with pharmaceutical drugs, for example by immunomodulating drugs. However, treatment options are limited at present. This report provides a detailed description of cognitive functions and performance in MS patients, their comorbidities such as fatigue and depression and therapeutic options.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Achiron A, Barak Y (2003) Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry 74:443–446

    Article  PubMed  CAS  Google Scholar 

  2. Amato MP, Ponziani G, Pracucci G et al. (1995) Cognitive impairment in early-onset multiple sclerosis. Arch Neurol 52:168–172

    PubMed  CAS  Google Scholar 

  3. Amato MP, Ponziani G, Siracusa G et al. (2001) Cognitive dysfunction in early-onset multiple sclerosis. Arch Neurol 58:1602–1606

    Article  PubMed  CAS  Google Scholar 

  4. Amato MP, Portaccio E, Zipoli V (2006) Are there protective treatments for cognitive decline in MS? J Neurol Sci 245:183–186

    Article  PubMed  CAS  Google Scholar 

  5. Arnett PA, Higginson CI, Voss WD et al. (2002) Relationship between coping, cognitive dysfunction and depression in multiple sclerosis. Clin Neuropsychol 16:341–355

    PubMed  Google Scholar 

  6. Arnett PA, Higginson CI, Voss WD et al. (1999) Depressed mood in multiple sclerosis: relationship to capacitydemanding memory and attentional functioning. Neuropsychology 13:434–446

    Article  PubMed  CAS  Google Scholar 

  7. Arnett PA, Rao SM, Bernardin L et al. (1994) Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis. Neurology 44:420–425

    PubMed  CAS  Google Scholar 

  8. Arnett PA, Rao SM, Grafman J et al. (1997) Executive functions in multiple sclerosis: an analysis of temporal ordering, semantic encoding and planning abilities. Neuropsychology 11:535–544

    Article  PubMed  CAS  Google Scholar 

  9. Bagert B, Camplair P, Bourdette D (2002) Cognitive dysfunction in multiple sclerosis.Natural history, pathophysiology and management. CNS Drugs 16:445–455

    Article  PubMed  Google Scholar 

  10. Bakshi R, Shaikh ZA, Miletich RS et al. (2000) Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler 6:181–185

    PubMed  CAS  Google Scholar 

  11. Barak Y, Achiron A (2002) Effect of Interferon-beta-1b on cognitive functions in multiple sclerosis. Eur Neurol 47:11–14

    Article  PubMed  CAS  Google Scholar 

  12. Barak Y, Gabbay U, Gilad R et al. (1999) Neuropsychiatric assessment as a secondary outcome measure in a multiple sclerosis intravenous immunoglobulin (IVIg) trial. Int J Psychiatr Clin Pract 3:31–34

    Google Scholar 

  13. Beatty WW, Goodkin DE, Monson N et al. (1989) Cognitive disturbances in patients with relapsing remitting multiple sclerosis. Arch Neurol 46:1113–1119

    PubMed  CAS  Google Scholar 

  14. Beatty WW, Goodkin DE, Monson N et al. (1990) Implicit learning in patients with chronic progressive multiple sclerosis. Int J Clin Neuropsychol 12:166–172

    Google Scholar 

  15. Beatty WW, Goretti B, Siracusa G et al. (2003) Changes in neuropsychological test performances over the workday in multiple sclerosis. Clin Neuropsychol 17:551–560

    PubMed  Google Scholar 

  16. Beatty WW, Monson N (1991) Metamemory in multiple sclerosis. J Clin Exp Neuropsychol 13:309–327

    PubMed  CAS  Google Scholar 

  17. Behmenburg C (1993) Attention deficits in patients with multiple sclerosis. Dissertation, Heinrich- Heine-Universität Düsseldorf

  18. Benedict RH, Cox D, Thompson LL et al. (2004) Reliable screening for neuropsychological impairment in multiple sclerosis. Mult Scler 10:675–678

    Article  PubMed  Google Scholar 

  19. Benedict RH, Shapiro A, Priore R et al. (2000) Neuropsychological counseling improves social behavior in cognitively-impaired multiple sclerosis patients. Mult Scler 6:391–396

    PubMed  CAS  Google Scholar 

  20. Bjartmar C, Trapp BD (2001) Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol 14:271–278

    Article  PubMed  CAS  Google Scholar 

  21. Bo L, Vedeler CA, Nyland H et al. (2003) Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 62:723–732

    PubMed  Google Scholar 

  22. Bruce JM, Arnett PA (2004) Self-reported everyday memory and depression in patients with multiple sclerosis. J Clin Exp Neuropsychol 26:200–214

    Article  PubMed  Google Scholar 

  23. Brunner R, Schaefer D, Hess K, Parzer P, Resch F, Schwab S (2005) Effect of corticosteroids on short-term and long term memory. Neurology 64:335–337

    PubMed  CAS  Google Scholar 

  24. Calabrese P, Haupts M, Babinsky R et al. (1993) Everyday memory in multiple sclerosis. Z Neuropsychol 4:4–16

    Google Scholar 

  25. Calabrese P, Haupts M, Gehlen W (2000) Memory deficits and lesion pattern in different courses of multiple sclerosis. Neurol Rehabil 6:184–188

    Google Scholar 

  26. Canter AH (1951) Direct and indirect measures of psychological deficits in multiple sclerosis. J Gen Psychol 44:3–50

    Article  Google Scholar 

  27. Charcot JM (1873) Leçons sur les maladies du système nerveux faites à la Salpêtrière. Delahaye, Paris

  28. Christodoulou C, Melville P, Scherl WF et al. (2006) Effects of donepezil on memory and cognition in multiple sclerosis. J Neurol Sci 245:127–136

    Article  PubMed  CAS  Google Scholar 

  29. Clark CM, Jacova C, Klonoff H et al. (1997) Pathological association and dissociation of functional systems in multiple sclerosis and huntington's disease. J Clin Exp Neuropsychol 19:63–76

    PubMed  CAS  Google Scholar 

  30. Comi G, Filippi M, Martinelli V et al. (1995) Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci 132:222–227

    Article  PubMed  CAS  Google Scholar 

  31. DeLuca J, Barbieri-Berger S, Johnson SK (1994) The nature of memory impairments in multiple sclerosis: acquisition versus retrieval. J Clin Exp Neuropsychol 16:183–189

    PubMed  CAS  Google Scholar 

  32. DeSonneville LMJ, Boringa JB, Reuling IE, Lazeron RH, Ader HJ, Polmann CD (2002) Information processing characteristics in subtypes of multiple sclerosis. Neuropsychologia 40:1751–1765

    Article  CAS  Google Scholar 

  33. Dujardin K, Donze A, Hautecoeur P (1998) Attention impairment in recently diagnosed multiple sclerosis. Eur J Neurol 5:61–66

    Article  PubMed  Google Scholar 

  34. Engel C, Greim B, Zettl UK (2004) Fatigue in multiple sclerosis. Neurol Rehabil 9:263–271

    Google Scholar 

  35. Engel C, Greim B, Zettl UK (2007) Diagnostics of cognitive dysfunctions in multiple sclerosis. J Neurol 254 (Suppl 2):30–34

    Google Scholar 

  36. Feinstein A (2004) The neuropsychiatry of multiple sclerosis. Can J Psychiatry 49:157–163

    PubMed  Google Scholar 

  37. Fischer JS, Priore RL, Jacobs LD et al. (2000) Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Ann Neurol 48:885–892

    Article  PubMed  CAS  Google Scholar 

  38. Flachenecker P, Kumpfel T, Kaltmann B et al. (2002) Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler 8:523–526

    Article  PubMed  CAS  Google Scholar 

  39. Foong J, Rozewicz L, Chong WK et al. (2000) A comparison of neuropsychological deficits in primary and secondary progressive multiple sclerosis. J Neurol 247:97–101

    Article  PubMed  CAS  Google Scholar 

  40. Foong J, Rozewicz L, Quaghebeur G et al. (1997) Executive function in multiple sclerosis. The role of frontal lobe pathology. Brain 120:15–26

    Article  PubMed  Google Scholar 

  41. Foong J, Rozewicz L, Quaghebeur G et al. (1998) Neuropsychological deficits in multiple sclerosis after acute relapse. J Neurol Neurosurg Psychiatry 64:529–532

    PubMed  CAS  Google Scholar 

  42. Fraser C, Stark S (2003) Cognitive symptoms and correlates of physical disability in individuals with multiple sclerosis. J Neurosci Nurs 35:314–320

    PubMed  Google Scholar 

  43. Grafman J, Rao S, Bernardin L et al. (1991) Automatic memory processes in patients with multiple sclerosis. Arch Neurol 48:1072–1075

    PubMed  CAS  Google Scholar 

  44. Grafman J, Rao SM, Litvan I (1990) Disorders of memory. In: Rao SM (ed) Neurobehavioral aspects of multiple sclerosis. Oxford, New York, pp 102–117

  45. Grant I, McDonald WI, Trimble MR et al. (1984) Deficient learning and memory in early and middle phases of multiple sclerosis. J Neurol Neurosurg Psychiatry 47:250–255

    PubMed  CAS  Google Scholar 

  46. Greene YM, Tariot PN, Wishart H et al. (2000) A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments. J Clin Psychopharmacol 20:350–356

    Article  PubMed  CAS  Google Scholar 

  47. Greim B, Engel C, Apel A, Zettl UK (2007) Fatigue in neuroimmunological diseases. J Neurol 254(Suppl 2):102–106

    Google Scholar 

  48. Haase C, Tinnefeld M, Lienemann M et al. (2003) Depression and cognitive impairment in disability-free early multiple sclerosis. Behav Neurol 14:39–45

    PubMed  Google Scholar 

  49. Haupts M, Calabrese P (1994) Multiple sclerosis and everyday memory. In: Haupts M (ed) Neurology and memory. Huber, Bern, pp 68–75

  50. Haupts M, Calabrese P, Greim B et al. (2001) Neuropsychological findings and treatment options in multiple sclerosis. In: Zettl UK, Mix E (eds) Multiple sclerosis: causal, symptomatic and rehabilitative treatment. Springer, Berlin Heidelberg New York, pp 251–270

  51. Haupts M, Calabrese P, Ließ J et al. (1996) Cerebral lesions in encephalitis disseminata: neuropsychological findings and rehabilitative strategies. In: Huffmann G, Braune HJ (eds) Cerebral and spinal diseases: Encephalitis disseminata, epilepsy, degenerative diseases, trauma, tumours, rehabilitation. Einhorn, Reinbek, pp 155–160

  52. Heaton RK, Nelson LM, Thompson DS et al. (1985) Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis. J Consult Clin Psychol 53:103–110

    Article  PubMed  CAS  Google Scholar 

  53. Henze T, Rieckmann P, Toyka KV (2006) Symptomatic Treatment of Multiple Sclerosis. Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society. Eur Neurol 56(2):78–105

    Article  PubMed  CAS  Google Scholar 

  54. Herholz K (2006) Cognitive dysfunction and emotional-behavioural changes in MS: The potential of positron emission tomography. J Neurol Sci 245:9–13

    Article  PubMed  Google Scholar 

  55. Hildebrandt H, Brokate B, Lanz M et al. (2003) Executive functions in patients with multiple sclerosis. Akt Neurol 30:118–126

    Article  Google Scholar 

  56. Ivnik RJ (1978) Neuropsychological stability in multiple sclerosis. J Consult Clin Psychol 46:913–923

    Article  PubMed  CAS  Google Scholar 

  57. Johnson SK, Diamond BJ, Rausch S et al. (2006) The Effect of Gingko Biloba on Functional Measures in Multiple Sclerosis: A Pilot Randomized Controlled Trial. Explore 2:19–24

    PubMed  Google Scholar 

  58. Jonsson A, Korfitzen EM, Heltberg A et al. (1993) Effects of neuropsychological treatment in patients with multiple sclerosis. Acta Neurol Scand 88:394–400

    PubMed  CAS  Google Scholar 

  59. Krupp LB, Alvarez LA, LaRocca NG et al. (1988) Fatigue in multiple sclerosis. Arch Neurol 45:435–437

    PubMed  CAS  Google Scholar 

  60. Krupp LB, Christodoulou C, Melville P et al. (2004) Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology 63:1579–1585

    PubMed  CAS  Google Scholar 

  61. Krupp LB, Elkins LE (2000) Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology 55:934–939

    PubMed  CAS  Google Scholar 

  62. Kujala P, Portin R, Revonsuo A et al. (1995) Attention related performance in two cognitively different subgroups of patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 59:77–82

    PubMed  CAS  Google Scholar 

  63. Kujala P, Portin R, Ruutiainen J (1997) The Progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. Brain 120:289–297

    Article  PubMed  Google Scholar 

  64. Leo GJ, Rao SM (1988) Effects of intravenous physostigmine and lecithin on memory loss in multiple sclerosis: report of a pilot study. J Neurol Rehab 2:123–129

    Google Scholar 

  65. Lincoln NB, Dent A, Harding J et al. (2002) Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis. J Neurol Neurosurg Psychiatry 72:93–98

    Article  PubMed  CAS  Google Scholar 

  66. Litvan I, Grafman J, Vendrell P et al. (1988) Multiple memory deficits in patients with multiple sclerosis. Arch Neurol 45:607–610

    PubMed  CAS  Google Scholar 

  67. Magnano I, Aiello I, Piras MR (2006) Cognitive impairment and neurophysiological correlates in MS. J Neurol Sci 245:117–122

    Article  PubMed  CAS  Google Scholar 

  68. Maor Y, Olmer L, Mozes B (2001) The relation between objective and subjective impairment in cognitive function among multiple sclerosis patients – the role of depression. Mult Scler 7:131–135

    PubMed  CAS  Google Scholar 

  69. Möller A, Wiedemann G, Rohde U et al. (1994) Correlates of cognitive impairment and depressive disorder in multiple sclerosis. Acta Psychiatr Scand 89:117–121

    PubMed  Google Scholar 

  70. Montalban X, Rio J (2006) Interferons and cognition. J Neurol Sci 245:137–140

    Article  PubMed  CAS  Google Scholar 

  71. Parmenter BA, Denney DR, Lynch SG (2003) The cognitive performance of patients with multiple sclerosis during periods of high and low fatigue. Mult Scler 9:111–118

    Article  PubMed  Google Scholar 

  72. Patti F, Failla G, Ciancio MR et al. (1998) Neuropsychological, neuroradiological and clinical findings in multiple sclerosis. A 3 year follow-up study. Eur J Neurol 5:283–286

    Article  PubMed  Google Scholar 

  73. Patzold T, Schwengelbeck M, Ossege LM et al. (2002) Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis. Acta Neurol Scand 105:164–168

    Article  PubMed  CAS  Google Scholar 

  74. Paul RH, Blanco CR, Hames KA et al. (1997) Autobiographical memory in multiple sclerosis. J Int Neuropsychol Soc 3:246–251

    PubMed  CAS  Google Scholar 

  75. Penner IK, Kappos L (2006) Retraining attention in MS. J Neurol Sci 245:147–151

    Article  PubMed  Google Scholar 

  76. Penner IK, Kappos L, Opwis K (2005) Induced changes in brain activation using a computerized attention training in patients with Multiple Sclerosis (MS). In: Opwis K, Penner IK (eds) Proceedings of KogWis05. The German Cognitive Science Conference. Schwabe, Basel, pp 201–206

  77. Penner IK, Opwis K, Kappos L (2007) Relation between functional brain imaging, cognitive impairment and cognitive rehabilitation in patients with multiple sclerosis. J Neurol 254 (Suppl 2):53–57

    Article  Google Scholar 

  78. Pelosi L, Geesken JM, Holly M et al. (1997) Working memory impairment in early multiple sclerosis. Evidence from an event-related potential study of patients with clinically isolated myelopathy. Brain 120:2039–2058

    Article  Google Scholar 

  79. Peterson JW, Bo L, Mork S et al. (2001) Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50:389–400

    Article  PubMed  CAS  Google Scholar 

  80. Piras MR, Magnano I, Canu ED et al. (2003) Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings. J Neurol Neurosurg Psychiatry 74:878–885

    Article  PubMed  CAS  Google Scholar 

  81. Pliskin NH, Hamer DP, Goldstein DS et al. (1996) Improved delayed visual reproduction test performances in multiple sclerosis patients receiving Interferon beta-1b. Neurology 47:1463–1468

    PubMed  CAS  Google Scholar 

  82. Plohmann AM, Kappos L, Ammann W et al. (1998) Computer assisted retraining of attentional impairments in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 64:455–462

    Article  PubMed  CAS  Google Scholar 

  83. Rao SM (1986) Neuropsychology of multiple sclerosis: a critical review. J Clin Exp Neuropsychol 8:503–542

    PubMed  CAS  Google Scholar 

  84. Rao SM, Grafman J, DiGiulio D et al. (1993) Memory dysfunction in multiple sclerosis: its relation to working memory, semantic encoding and implicit learning. Neuropsychology 7:364–374

    Article  Google Scholar 

  85. Rao SM, Leo GJ, Bernardin L et al. (1991) Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41:685–691

    PubMed  CAS  Google Scholar 

  86. Rao SM, Leo GJ, Ellington L et al. (1991) Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 41:692–696

    PubMed  CAS  Google Scholar 

  87. Rodriguez M, Siva A, Ward J et al. (1994) Impairment, disability, and handicap in multiple sclerosis. A population- based study in Olmsted County, Minnesota. Neurology 44:28–33

    PubMed  CAS  Google Scholar 

  88. Rovaris M, Filippi M, Falautano M et al. (1998) Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 50:1601–1608

    PubMed  CAS  Google Scholar 

  89. Ruggieri RM, Palermo R, Vitello G et al. (2003) Cognitive impairment in patients suffering from relapsing-remitting multiple sclerosis with EDSS < 3.5. Acta Neurol Scand 108:323–326

    Article  PubMed  CAS  Google Scholar 

  90. Sartori E, Edan G (2006) Assessment of cognitive dysfunction in multiple sclerosis. J Neurol Sci 245:169–175

    Article  PubMed  Google Scholar 

  91. Schiffer RB, Caine ED (1991) The interaction between depressive affective disorder and neuropsychological test performance in multiple sclerosis patients. J Neuropsychiatry Clin Neurosci 3:28–32

    PubMed  CAS  Google Scholar 

  92. Schreurs K, de Ridder D, Bensing J (2002) Fatigue in multiple sclerosis: reciprocal relationships with physical disabilities and depression. J Psychosom Res 53:775–781

    Article  PubMed  Google Scholar 

  93. Selby MJ, Ling N, Williams JM et al. (1998) Interferon beta 1-b in verbal memory functioning of patients with relapsing-remitting multiple sclerosis. Percept Mot Skills 86:1099–1106

    PubMed  CAS  Google Scholar 

  94. Sperling RA, Guttmann CR, Hohol MJ et al. (2001) Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis. Arch Neurol 58:115–12

    Article  PubMed  CAS  Google Scholar 

  95. Sturm W, Hartje W, Orgass B et al. (1993) Computer-assisted rehabilitation of attention impairments. In: Stachowiak F, De Bleser R (eds) Developments in the assessment and rehabilitation of brain-damaged patients: perspectives from a European concerted action. Günther Narr, Tübingen, pp 49–54

  96. Thomas PW, Thomas S, Hillier C et al. (2006) Psychological interventions for multiple sclerosis. Cochrane Database Syst Rev Issue 1, Art.No.: CD004431. pub2. pp 1–51

  97. Thornton AE, Raz N (1997) Memory impairment in multiple sclerosis: a quantitative review. Neuropsychology 11:357–366

    Article  PubMed  CAS  Google Scholar 

  98. Unverzagt FW, Rao SM, Antuono PG (1991) Oral physostigmine in the treatment of memory loss in multiple sclerosis (MS). J Clin Exp Neuropsychol 131:74

    Google Scholar 

  99. Uttner I, Müller S, Zinser C, Gold R, Tumani H et al. (2005) Reversible impaired memory induced by pulsed methylprednisolone in patients with MS. Neurology 64:1971–1973

    Article  PubMed  CAS  Google Scholar 

  100. Wachowius U, Talley M, Silver N, Heinze HJ, Sailer M (2005) Cognitive impairment in primary and secondary progressive multiple sclerosis. J Clin Exp Neuropsychol 27:65–77

    PubMed  Google Scholar 

  101. Weinstein A, Schwid SI, Schiffer RB et al. (1999) Neuropsychologic status in multiple sclerosis after treatment with glatiramer. Arch Neurol 56:319–324

    Article  PubMed  CAS  Google Scholar 

  102. Zéphir H, deSeze J, Dujardin K et al. (2005) One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis. Mult Scler 11:360–363

    Article  PubMed  Google Scholar 

  103. Zivadinov R, Sepcic J, Nasuelli D et al. (2001) A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 70:773–780

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Rostock, Gehlsheimer Straße 20, 18147, Rostock, Germany

    Alexander Winkelmann, Claudia Engel, Annett Apel & Uwe K. Zettl

Authors
  1. Alexander Winkelmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudia Engel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Annett Apel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Uwe K. Zettl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Uwe K. Zettl.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/s00415-008-0901-z.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Winkelmann, A., Engel, C., Apel, A. et al. Cognitive impairment in multiple sclerosis. J Neurol 254 (Suppl 2), II35–II42 (2007). https://doi.org/10.1007/s00415-007-2010-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-007-2010-9

Key words

Search

Navigation